NORTH PARK, September 25, 2016 /PRNewswire/ — Biocept, Inc. (NASDAQ: BIOC), a molecular diagnostics firm commercializing and developing biomarkers to enhance the recognition and therapy of cancer, declares that it’ll launch fiscal outcomes for that three and 6 months ended June 30, 2016 prior to the marketplace starts on Tuesday, August 2, 2016. The Organization will even host a conference demand the expense group to go over the outcomes and response inquiries at 11:00 a.m. Eastern time (8:00 a.m. Pacific time).
People thinking about engaging about the conference phone can do so by calling (855) 656-0927 for domestic callers, (855) 669-9657 for Canadian callers, or (412) 902-4109 for additional international callers. These thinking about hearing a webcast of the live conference phone can do so at https://www.webcaster4.com/Webcast/Site/1271/16416
A replay of the conference phone is likely to be readily available for 48-hours following a summary of the phone call by calling (877) 344-7529 for domestic callers, (855) 669-9658 for Canadian callers, or (412) 317-0088 for additional overseas callers, and entering replay entry signal 10090461. A webcast replay is likely to be readily available for 3 months at http://ir.biocept.com/events.cfm.
Biocept, Inc. is just a molecular diagnostics company with commercialized assays for lung, chest, gastric, colorectal and prostate cancers, and melanoma. The Organization employs its amazing fluid biopsy engineering to supply doctors with information for managing and checking individuals identified as having cancer. The Business’s complex Goal Selector&industry; fluid biopsy technology system catches and examines growth-connected molecular indicators in both moving tumor tissues (CTCs) as well as in lcd (ctDNA). With a large number of assessments done, the system has shown the capability to determine cancer strains and modifications to see doctors in regards to a individual’s illness and healing options. For extra information, please visit www.biocept.com.
SUPPLY Biocept, Inc.